Literature DB >> 29394184

Cerebral Autoregulation in the Prediction of Delayed Cerebral Ischemia and Clinical Outcome in Poor-Grade Aneurysmal Subarachnoid Hemorrhage Patients.

Max Gaasch1, Alois J Schiefecker1, Mario Kofler1, Ronny Beer1, Verena Rass1, Bettina Pfausler1, Claudius Thomé2, Erich Schmutzhard1, Raimund Helbok1.   

Abstract

OBJECTIVES: Pressure reactivity index and oxygen reactivity index are used to assess cerebral autoregulation after acute brain injury. The value of autoregulation indices in the prediction of delayed cerebral ischemia and outcome in patients with subarachnoid hemorrhage is still inconclusive. In this study, we aimed to focus on the predictive value of the first 72 hours commonly referred to as "early brain injury" in comparison to the overall monitoring period.
DESIGN: Retrospective observational cohort study.
SETTING: Neurocritical care unit at a tertiary academic medical center. PATIENTS: Forty-three consecutive poor-grade patients with nontraumatic subarachnoid hemorrhage admitted between 2012 and 2016 undergoing continuous high-frequency monitoring.
INTERVENTIONS: High-frequency monitoring includes arterial blood pressure, intracranial pressure, and brain tissue oxygen tension. Pressure reactivity index and oxygen reactivity index were evaluated as moving correlation coefficient between mean arterial pressure/intracranial pressure and cerebral perfusion pressure/brain tissue oxygen tension, respectively.
MEASUREMENTS AND MAIN RESULTS: Median autoregulation monitoring time was 188 ± 91 hours per patient. Initial pressure reactivity index was 0.31 ± 0.02 and decreased significantly to 0.01 ± 0.01 (p < 0.001) 3 days after admission with a second peak 10 days after admission (0.18 ± 0.14; p = 0.001). Admission oxygen reactivity index was high, 0.25 ± 0.03, and decreased to a minimum of 0.11 ± 0.02 eight days after admission (p = 0.008). Patients with delayed cerebral ischemia had significantly higher overall mean pressure reactivity index values (p < 0.04), which were more pronounced during the first 72 hours, reflecting early brain injury (p < 0.02). High pressure reactivity index during the first 72 hours was associated with poor functional outcome (p < 0.001). No association between oxygen reactivity index and delayed cerebral ischemia or clinical outcome was observed (p = 0.8/0.78).
CONCLUSIONS: High initial pressure reactivity index, presumably reflecting early brain injury, but not oxygen reactivity index, was associated with delayed cerebral ischemia and worse clinical outcome in poor-grade subarachnoid hemorrhage patients. Our data indicate that autoregulation indices should be interpreted cautiously when used in these patients and that timing is crucial when autoregulation indices are evaluated as predictor for delayed cerebral ischemia and outcome.

Entities:  

Mesh:

Year:  2018        PMID: 29394184     DOI: 10.1097/CCM.0000000000003016

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  12 in total

1.  Long-term impairment of neurovascular coupling following experimental subarachnoid hemorrhage.

Authors:  Matilde Balbi; Max Jativa Vega; Athanasios Lourbopoulos; Nicole A Terpolilli; Nikolaus Plesnila
Journal:  J Cereb Blood Flow Metab       Date:  2019-07-11       Impact factor: 6.200

Review 2.  Impact of Cerebral Autoregulation Monitoring in Cerebrovascular Disease: A Systematic Review.

Authors:  Mais Al-Kawaz; Sung-Min Cho; Rebecca F Gottesman; Jose I Suarez; Lucia Rivera-Lara
Journal:  Neurocrit Care       Date:  2022-04-05       Impact factor: 3.210

Review 3.  Review of studies on dynamic cerebral autoregulation in the acute phase of stroke and the relationship with clinical outcome.

Authors:  Ricardo C Nogueira; Marcel Aries; Jatinder S Minhas; Nils H Petersen; Li Xiong; Jana M Kainerstorfer; Pedro Castro
Journal:  J Cereb Blood Flow Metab       Date:  2021-09-13       Impact factor: 6.960

4.  Cerebral Autoregulation Correlation With Outcomes and Spreading Depolarization in Aneurysmal Subarachnoid Hemorrhage.

Authors:  Bryce Owen; Adarsh Vangala; Chanju Fritch; Ali A Alsarah; Tom Jones; Herbert Davis; C William Shuttleworth; Andrew P Carlson
Journal:  Stroke       Date:  2022-02-24       Impact factor: 10.170

Review 5.  The value of early CT perfusion parameters for predicting delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis.

Authors:  Heze Han; Yu Chen; Runting Li; Fa Lin; Junlin Lu; Xiaolin Chen; Shuo Wang
Journal:  Neurosurg Rev       Date:  2022-04-04       Impact factor: 2.800

6.  Deviation From Personalized Blood Pressure Targets Is Associated With Worse Outcome After Subarachnoid Hemorrhage.

Authors:  Andrew Silverman; Sreeja Kodali; Sumita Strander; Emily J Gilmore; Alexandra Kimmel; Anson Wang; Branden Cord; Guido Falcone; Ryan Hebert; Charles Matouk; Kevin N Sheth; Nils H Petersen
Journal:  Stroke       Date:  2019-09-09       Impact factor: 7.914

Review 7.  Regulation of cerebral blood flow in humans: physiology and clinical implications of autoregulation.

Authors:  Jurgen A H R Claassen; Dick H J Thijssen; Ronney B Panerai; Frank M Faraci
Journal:  Physiol Rev       Date:  2021-03-26       Impact factor: 37.312

8.  Temporal Dynamics of ICP, CPP, PRx, and CPPopt in High-Grade Aneurysmal Subarachnoid Hemorrhage and the Relation to Clinical Outcome.

Authors:  Teodor Svedung Wettervik; Timothy Howells; Anders Lewén; Elisabeth Ronne-Engström; Per Enblad
Journal:  Neurocrit Care       Date:  2021-01-09       Impact factor: 3.210

Review 9.  Antioxidant Melatonin: Potential Functions in Improving Cerebral Autoregulation After Subarachnoid Hemorrhage.

Authors:  Zhen-Ni Guo; Hang Jin; Huijie Sun; Yingkai Zhao; Jia Liu; Hongyin Ma; Xin Sun; Yi Yang
Journal:  Front Physiol       Date:  2018-08-17       Impact factor: 4.566

10.  Early Transcranial Doppler Evaluation of Cerebral Autoregulation Independently Predicts Functional Outcome After Aneurysmal Subarachnoid Hemorrhage.

Authors:  Carla B Rynkowski; Airton Leonardo de Oliveira Manoel; Marcelo Martins Dos Reis; Corina Puppo; Paulo Valdeci Worm; Diego Zambonin; Marino Muxfeldt Bianchin
Journal:  Neurocrit Care       Date:  2019-10       Impact factor: 3.210

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.